<code id='0456386C1C'></code><style id='0456386C1C'></style>
    • <acronym id='0456386C1C'></acronym>
      <center id='0456386C1C'><center id='0456386C1C'><tfoot id='0456386C1C'></tfoot></center><abbr id='0456386C1C'><dir id='0456386C1C'><tfoot id='0456386C1C'></tfoot><noframes id='0456386C1C'>

    • <optgroup id='0456386C1C'><strike id='0456386C1C'><sup id='0456386C1C'></sup></strike><code id='0456386C1C'></code></optgroup>
        1. <b id='0456386C1C'><label id='0456386C1C'><select id='0456386C1C'><dt id='0456386C1C'><span id='0456386C1C'></span></dt></select></label></b><u id='0456386C1C'></u>
          <i id='0456386C1C'><strike id='0456386C1C'><tt id='0456386C1C'><pre id='0456386C1C'></pre></tt></strike></i>

          Home / fashion / comprehensive

          comprehensive


          comprehensive

          author:hotspot    Page View:5817
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In